Apollo Ingredients Limited has filed an appeal before the Securities Appellate Tribunal (SAT) against BSE Limited, challenging regulatory actions taken by the stock exchange. The company, formerly known as Indsoya Limited, made this disclosure on January 27, 2026, in compliance with SEBI regulations.

Appeal Details

The appeal has been filed in response to actions taken by BSE Limited against the company's promoter group. The exchange had imposed fines and frozen demat accounts of the promoter group for alleged non-compliance with provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Actions Challenged

The appeal specifically contests BSE's enforcement measures that included:

• Imposition of fines on the promoter group
• Freezing of demat accounts belonging to the promoter group
• Actions related to alleged LODR regulation violations

These measures were implemented by BSE Limited as part of its regulatory oversight function for listed companies and their compliance with disclosure requirements.

Current Status

The matter is currently under consideration before the Securities Appellate Tribunal. Apollo Ingredients Limited has committed to making further disclosures as required, in accordance with applicable legal provisions, as the appeal proceedings progress.

Company Information

Apollo Ingredients Limited, with scrip code 503639 on BSE, is registered in Maharashtra with its office located in Thane. The company secretary and compliance officer Ayushi Agrawal signed the regulatory filing, ensuring compliance with Regulation 30 of the SEBI LODR Regulations, 2015, which mandates disclosure of material events and information.

Indsoya Limited, now known as Apollo Ingredients Limited, has taken a significant step towards ensuring transparency and regulatory compliance for its upcoming rights issue. The company has appointed Infomerics Valuation and Rating Limited as the monitoring agency to oversee the utilization of funds raised through the rights issue.

Appointment Details

The appointment of Infomerics is in line with the Securities and Exchange Board of India (SEBI) Issue of Capital and Disclosure Requirements (ICDR) Regulations, 2018. This move demonstrates Apollo Ingredients' commitment to maintaining high standards of corporate governance and transparency in its financial operations.

About Infomerics

Infomerics Valuation and Rating Limited is a well-established entity in the financial sector:

• SEBI Registration: IN/CRA/00722015 (Perpetual validity)
• Corporate Address: Office No-1102, 1103, 1104 B- Wing, Kanakia Wall Street, off, Andheri- Kurla Rd. Andheri East. Mumbai, Maharashtra-400093
• Website: https://www.infomerics.com/

Consent and Documentation

Infomerics has provided its consent to act as the monitoring agency for Apollo Ingredients Limited's rights issue. The consent letter authorizes the inclusion of Infomerics' name in the following documents:

1. Draft Letter of Offer (DLoF)
2. Letter of Offer (LoF)
3. Other issue-related documents

These documents will be filed with:

• Stock exchanges (BSE and NSE) with nationwide trading terminals
• Registrar of Companies, Mumbai (RoC)
• Securities and Exchange Board of India (SEBI)
• Other relevant regulatory authorities

Regulatory Compliance

The appointment of a monitoring agency is a crucial step in the rights issue process, ensuring that the funds raised are utilized in accordance with the stated objectives. This compliance measure aligns with Section 62 and other applicable provisions of the Companies Act, 2013.

Timeline

Apollo Ingredients Limited, trading under the scrip code 503639 on the BSE, has promptly submitted the consent letter to the stock exchange, demonstrating its commitment to keeping shareholders and regulatory bodies informed about the progress of its rights issue.

This appointment marks an important milestone in Apollo Ingredients Limited's capital raising efforts, providing assurance to investors about the proper utilization of funds and adherence to regulatory standards throughout the rights issue process.